159 related articles for article (PubMed ID: 17080916)
1. Diminished expression of complement regulatory proteins (CD55 and CD59) in lymphocytes from systemic lupus erythematosus patients with lymphopenia.
García-Valladares I; Atisha-Fregoso Y; Richaud-Patin Y; Jakez-Ocampo J; Soto-Vega E; Elías-López D; Carrillo-Maravilla E; Cabiedes J; Ruiz-Argüelles A; Llorente L
Lupus; 2006; 15(9):600-5. PubMed ID: 17080916
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD55 and CD59 on peripheral blood cells from systemic lupus erythematosus (SLE) patients.
Alegretti AP; Mucenic T; Merzoni J; Faulhaber GA; Silla LM; Xavier RM
Cell Immunol; 2010; 265(2):127-32. PubMed ID: 20727519
[TBL] [Abstract][Full Text] [Related]
3. Abnormalities in the expression of CD55 and CD59 surface molecules on peripheral blood cells are not specific to paroxysmal nocturnal hemoglobinuria.
Ruiz-Delgado GJ; Vázquez-Garza E; Méndez-Ramírez N; Gómez-Almaguer D
Hematology; 2009 Feb; 14(1):33-7. PubMed ID: 19154662
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of red cell bound CD55 and CD59 in patients with systemic lupus erythematosus.
Richaud-Patin Y; Pérez-Romano B; Carrillo-Maravilla E; Rodriguez AB; Simon AJ; Cabiedes J; Jakez-Ocampo J; Llorente L; Ruiz-Argüelles A
Immunol Lett; 2003 Aug; 88(2):95-9. PubMed ID: 12880676
[TBL] [Abstract][Full Text] [Related]
5. Expression levels of CD47, CD35, CD55, and CD59 on red blood cells and signal-regulatory protein-alpha,beta on monocytes from patients with warm autoimmune hemolytic anemia.
Barros MM; Yamamoto M; Figueiredo MS; Cançado R; Kimura EY; Langhi DM; Chiattone CS; Bordin JO
Transfusion; 2009 Jan; 49(1):154-60. PubMed ID: 18954403
[TBL] [Abstract][Full Text] [Related]
6. The role of complement regulatory proteins (CD55 and CD59) in the pathogenesis of autoimmune hemocytopenias.
Ruiz-Argüelles A; Llorente L
Autoimmun Rev; 2007 Jan; 6(3):155-61. PubMed ID: 17289551
[TBL] [Abstract][Full Text] [Related]
7. Expression of GPI-anchored complement regulatory proteins CD55 and CD59 differentiates two subpopulations of human CD56+ CD3- lymphocytes (NK cells).
Solomon KR; Chan M; Finberg RW
Cell Immunol; 1995 Oct; 165(2):294-301. PubMed ID: 7553895
[TBL] [Abstract][Full Text] [Related]
8. Diminished expression of complement regulatory proteins on peripheral blood cells from systemic lupus erythematosus patients.
Alegretti AP; Schneider L; Piccoli AK; Monticielo OA; Lora PS; Brenol JC; Xavier RM
Clin Dev Immunol; 2012; 2012():725684. PubMed ID: 22761633
[TBL] [Abstract][Full Text] [Related]
9. Expression pattern of CD55 and CD59 on red blood cells in sickle cell disease.
Al-Faris L; Al-Rukhayes M; Al-Humood S
Hematology; 2017 Mar; 22(2):105-113. PubMed ID: 27667587
[TBL] [Abstract][Full Text] [Related]
10. Antibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59.
Schmitz J; Zimmer JP; Kluxen B; Aries S; Bögel M; Gigli I; Schmitz H
J Clin Invest; 1995 Sep; 96(3):1520-6. PubMed ID: 7544808
[TBL] [Abstract][Full Text] [Related]
11. Membrane-bound complement regulatory proteins are prognostic factors of operable breast cancer treated with adjuvant trastuzumab: a retrospective study.
Liu M; Yang YJ; Zheng H; Zhong XR; Wang Y; Wang Z; Wang YG; Wang YP
Oncol Rep; 2014 Dec; 32(6):2619-27. PubMed ID: 25241923
[TBL] [Abstract][Full Text] [Related]
12. The expressions of Toll-like receptor 9 and T-bet in circulating B and T cells in newly diagnosed, untreated systemic lupus erythematosus and correlations with disease activity and laboratory data in a Chinese population.
Wu O; Chen GP; Chen H; Li XP; Xu JH; Zhao SS; Sheng J; Feng JB; Cai J; Fang XH; Zhang WH; Li LH; Zhang N; Li J; Li JJ; Pan FM; Wang CZ; Ye DQ
Immunobiology; 2009; 214(5):392-402. PubMed ID: 19362685
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD55 and CD59 on peripheral blood cells in patients with lymphoproliferative disease of granular lymphocytes.
Isoda A; Tsukamoto N; Mitsui T; Yamane A; Hatsumi N; Matsushima T; Murakami H; Nojima Y; Karasawa M
Int J Lab Hematol; 2007 Feb; 29(1):52-7. PubMed ID: 17224008
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies to T and B cell lines detected in serum samples from patients with systemic lupus erythematosus with lymphopenia and hypocomplementaemia.
Noguchi M; Iwamori M; Hirano T; Kobayashi S; Hashimoto H; Hirose S; Nagai Y
Ann Rheum Dis; 1992 Jun; 51(6):713-6. PubMed ID: 1616351
[TBL] [Abstract][Full Text] [Related]
15. Activation/inactivation of the classical pathway of complement in non-lesional skin of patients with systemic lupus erythematosus.
Alahlafi A; Wordsworth P; Wojnarowska F
J Cutan Pathol; 2005 Sep; 32(8):537-40. PubMed ID: 16115051
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of complement regulatory proteins, CD55 and CD59, on peripheral blood leucocytes in patients with type 2 diabetes and macrovascular diseases.
Ma XW; Chang ZW; Qin MZ; Sun Y; Huang HL; He Y
Chin Med J (Engl); 2009 Sep; 122(18):2123-8. PubMed ID: 19781296
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis.
Gorter A; Blok VT; Haasnoot WH; Ensink NG; Daha MR; Fleuren GJ
Lab Invest; 1996 Jun; 74(6):1039-49. PubMed ID: 8667608
[TBL] [Abstract][Full Text] [Related]
18. Use of complement regulators, CD35, CD46, CD55, and CD59, on leukocytes as markers for diagnosis of viral and bacterial infections.
Nuutila J; Jalava-Karvinen P; Hohenthal U; Kotilainen P; Pelliniemi TT; Nikoskelainen J; Lilius EM
Hum Immunol; 2013 May; 74(5):522-30. PubMed ID: 23376460
[TBL] [Abstract][Full Text] [Related]
19. Membrane-bound regulators of complement activation in uveal melanomas. CD46, CD55, and CD59 in uveal melanomas.
Goslings WR; Blom DJ; de Waard-Siebinga I; van Beelen E; Claas FH; Jager MJ; Gorter A
Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1884-91. PubMed ID: 8759358
[TBL] [Abstract][Full Text] [Related]
20. Reduced expression of CD55 and CD59 on peripheral blood cells from systemic lupus erythematosus: profitable to diagnose some complications?
Xu WD; Zhang YJ; Zhou M; Peng H; Liu SS; Ye DQ
Cell Immunol; 2011; 271(1):15. PubMed ID: 21802665
[No Abstract] [Full Text] [Related]
[Next] [New Search]
